Yes the article is missing a lot of things - it's pretty lazy. I am glad they included this snippet from Mel.
"Melinda Lancaster, whose daughter Katelin has Rett syndrome and was in the first clinical trial of Daybue, says her family’s life has been transformed since the treatment was approved in the US.“Her gross motor skills continue to improve. It kinda snuck up on me, but she’s eaten her whole breakfast by herself for the last two weeks using utensils. Incredible! Her balance just blows my mind, and she’s taken to walking more, especially over the last couple of weeks,” Lancester wrote on her blog last month."
Yes the article is missing a lot of things - it's pretty lazy. I...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$12.85 |
Change
-0.110(0.85%) |
Mkt cap ! $1.598B | |||
| Open | High | Low | Value | Volume |
| $12.82 | $13.05 | $12.53 | $6.559M | 511.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1657 | $12.83 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $12.85 | 6303 | 1 |
View Market Depth
| Last trade - 16.10pm 17/06/2025 (20 minute delay) ? |
| NEU (ASX) Chart |